Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Taking potassium chloride and magnesium stopped minoxidil-induced palpitations. The user is considering continuing minoxidil with these supplements.

The user is using topical dutasteride, minoxidil, and spironolactone for hair loss, with positive results after adding spironolactone. Another user takes oral spironolactone, dutasteride, and finasteride, noting decreased libido but no major side effects.

Hair loss treatments like spironolactone often require lifelong use to maintain results. Stopping the medication can lead to increased testosterone levels and potential hair loss.

Dutasteride is causing rapid changes in skin oiliness, leading to a switch in skincare routine. Users discuss its effects on hair and skin, with some experiencing drier hair.

A user from Ireland is seeking topical dutasteride with trichosol, which is unavailable in Ireland, and is looking for European pharmacies that can provide it. Recommendations include pharmacies in Switzerland, Italy, Belgium, and Bucharest, with mixed reviews about Farmacia Parati in Italy.

Creatine may not significantly boost libido despite potentially raising DHT levels. Finasteride reduces DHT and may affect libido, but individual experiences vary.

Dutasteride isn't effectively reducing DHT levels, prompting a switch back to finasteride. The user questions the reliability of their DHT test results due to hair loss concerns.

Oral minoxidil can cause facial bloating, leading to a puffy appearance. Some users report improvement after stopping the medication.

The user added dutasteride once a week for three months and shared blood work results, noting low vitamin D. Another user mentioned experiencing hair thinning while on the same treatment.

Breezula (clascoterone) Phase 3 hair loss trial results are delayed, with no official updates yet. The acne version is approved, but hair loss results are still pending.

A 30-year-old male experienced worsened hair thinning after trying topical minoxidil/finasteride and then undergoing three sessions of Dutasteride mesotherapy. Despite consistent use of 5% minoxidil, his hair condition deteriorated, and he suspects a shedding phase or adverse reaction to the treatments.

Some individuals taking finasteride for hair loss report increased libido and frequent masturbation, with no immediate hair regrowth but darker hair appearance. A dermatologist explains that finasteride may raise testosterone levels temporarily, which could lead to increased sex drive in some people.

Hair mesotherapy with dutasteride is popular in Europe and can be effective, especially when combined with oral dutasteride. Some users suggest using topical dutasteride with microneedling as an alternative, though it may be painful.

Dutasteride is considered safe for conception, with semen concentrations being too low to cause harm. Users discuss switching between dutasteride and finasteride, with some experiencing side effects like acne and heart issues, and advice is given to maintain a consistent treatment regimen.

High estradiol levels may contribute to erectile dysfunction (ED) and can be addressed with lifestyle changes or medication. It's important to consult a medical professional for treatment options.

A 25-year-old male has been using finasteride for 17 months and recently switched to dutasteride. His bloodwork shows increased luteinizing hormone levels, possibly due to increased testosterone, with no side effects and improved libido.

Dutasteride users report mixed experiences, with some experiencing significant hair shedding and others seeing improvement after initial shedding. Many users switch from finasteride to dutasteride, hoping for better results, but reactions vary widely, with some facing allergies or worsening hair loss.

Dutasteride users report initial hair shedding, often starting within the first two months, but many experience hair thickening after several months. Shedding is seen as a sign of the medication working.

Breezula's phase 2 showed reduced efficacy after 6 months, but phase 3 had positive results, causing confusion about any changes made to the drug. There is frustration over the long timeline for hair loss treatments, with some users expressing more interest in other potential treatments like GT-20029.

The user is concerned about hair loss despite taking finasteride and has a hair transplant scheduled. They experience scalp itching and burning, which hasn't been relieved by various treatments, and another user suggests using ghk-cu & ahk-cu serum and Koshine kx-826/pyrilutamide for relief.

Clascoterone 5% solution showed a 539% improvement in hair count compared to placebo, but the actual increase in hair growth is minimal. Users express skepticism about the effectiveness of hair loss treatments.

The conversation is about making a topical solution from clascoterone powder, with references to using a RU58841 mixing guide for guidance. Concerns about product authenticity and bulk purchase requirements are also discussed.

Botox may help with hair loss by reducing muscle tension and inflammation, potentially lowering DHT levels. Regular sessions might be needed, and it could also help with migraines.

The conversation discusses the effectiveness of dutasteride injections for hair loss, often paired with oral minoxidil and oral finasteride/dutasteride. The user is seeking information on U.S. clinics offering this treatment.

The user experienced significant hair regrowth and improved appearance using dutasteride, with no side effects, and is concerned about whether gym workouts and creatine might affect these gains. They previously used minoxidil but disliked its effects and stopped due to its inconvenience.

The conversation discusses the possibility and safety of adding minoxidil sulfate to mesotherapy with dutasteride. Users are inquiring if anyone has tried this combination.

Concerns about finasteride affecting sperm quality and embryo abnormalities during IVF. The user plans to stop finasteride for 6 months and use minoxidil, microneedling, a red light cap, and saw palmetto shampoo to manage hair loss.

Clascoterone's European release is expected in Q4 2026, with FDA approval anticipated by mid-2027. The discussion includes questions about the approval timeline and potential acceleration due to unmet needs.

The conversation is about a user struggling with hair loss despite using dutasteride, finasteride, minoxidil, and dermaneedling. The user is considering other treatments but is hesitant to use RU-58841 due to side effects and is seeking advice on alternative solutions.

Dutasteride is more effective than finasteride for hair loss, with some users experiencing fewer side effects. Users share experiences with dutasteride, finasteride, minoxidil, and biotin, discussing dosage and fertility concerns.